Antimycobacterial activity against wild type Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 21 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis NTB1 harboring DprE1 G387S mutant assessed as inhibition of bacterial growth measured after 21 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis DR1 harboring mmpL3 V681I mutant assessed as inhibition of bacterial growth measured after 21 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis 88.7 harboring pyrG V186G mutant assessed as inhibition of bacterial growth measured after 21 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis 53.3 harboring Rv2466c W28S mutant assessed as inhibition of bacterial growth measured after 21 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis Ty1 harboring Rv3405c C190T mutant assessed as inhibition of bacterial growth measured after 21 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis 81.10 harboring EthA del (1109 to 37 residues) mutant assessed as inhibition of bacterial growth measured after 21 days by microbroth dilution method
Antimycobacterial activity against streptomycin, isoniazid, rifampicin, ethambutol, pyrazinamide, ethionamide and capreomycin resistant Mycobacterium tuberculosis IC2 assessed as inhibition of bacterial growth measured after 21 days by microbroth dilution method
Antimycobacterial activity against 14C acetate-labeled Mycobacterium tuberculosis H37Ra assessed as inhibition of bacterial growth at 42 uM incubated for 24 hrs by autoradiography based TLC analysis relative to control
Antimycobacterial activity against 14C acetate-labeled Mycobacterium tuberculosis H37Ra assessed as inhibition of bacterial growth at 84 uM incubated for 24 hrs by autoradiography based TLC analysis relative to control
Antimycobacterial activity against 14C acetate-labeled Mycobacterium tuberculosis H37Ra assessed as reduction in trehalose dimycolates level at 42 to 84 uM incubated for 24 hrs by autoradiography based TLC analysis
Antimycobacterial activity against 14C acetate-labeled Mycobacterium tuberculosis H37Ra assessed as reduction in trehalose monomycolates level at 42 to 84 uM incubated for 24 hrs by autoradiography based TLC analysis
Antimycobacterial activity against 14C acetate-labeled Mycobacterium tuberculosis H37Ra assessed as reduction in cell wall bound mycolic acid level at 42 to 84 uM incubated for 24 hrs by autoradiography based TLC analysis
Antimycobacterial activity against Mycobacterium smegmatis MC2 155 assessed as inhibition of bacterial growth at 16.8 uM incubated for 16 hrs relative to control
Antimycobacterial activity against Mycobacterium smegmatis MC2 155 assessed as reduction in trehalose monomycolates level at 16.8 uM incubated for 16 hrs by TLC analysis
Antimycobacterial activity against Mycobacterium smegmatis MC2 155 assessed as reduction in cell wall bound mycolic acid methyl esters at 16.8 uM incubated for 16 hrs by TLC analysis
Antimycobacterial activity against Mycobacterium smegmatis MC2 155 assessed as reduction in trehalose dimycolates level at 16.8 uM incubated for 16 hrs by TLC analysis
Antimycobacterial activity against Mycobacterium smegmatis MC2 155 assessed as reduction in phosphatidylethanolamine synthesis at 16.8 uM incubated for 16 hrs by TLC analysis